Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05288140

Efficacy of the Use of Diaries in Intensive Care Units

Randomized clinical trial that aims to evaluate the impact of the use of a diary in patients and relatives of patients admitted to an ICU in relation to usual practice in terms of health-related quality of life, the post-traumatic stress and anxiety/depression at 2, 6 and 12 months after ICU discharge.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universidad de Barcelona

Barcelona, 08185, Spain

Location status: Recruiting

Location contact

pilar muñoz rey

CONTACT

[email protected]

639534904

About this study

Randomized, parallel, open, non-blinded, multicenter clinical trial, with an experimental group (diary) and a control group (usual practice), to compare the effect produced on quality of life by post-traumatic stress and anxiety/depression of patients and relatives, whether or not they have access to a diary during the stay in the unit. Three validated scales will be used at three different times. 120 cases per group, carrying out a preliminary pilot test. Data analysis according to IBM SPSS v.24 to describe and compare both groups.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • admitted intensive care unit
  • sedated and mechanically ventilated for 24hours
  • signed consent
  • not language barrier
  • willingness to attend follow-up visits

Exclusion criteria

  • verbal manifestation of psychiatric, mental or cognitive antecedents
  • who do not coluntarily agree to participate

Treatment and study plan

use of diary

Other

a diary is made for the experimental group where the events and events during the period of sedation and intubation are explained

Primary outcomes

  1. Hospital Anxiety and Depression Scale (HADS)

    Time frame: 2 months

    questionnaries, range of 0-21 for either anxiety and depression subscores. Higher scores corresponding to worse outcomes. 0-7 normal; 8-10 borderline abnormal; 11-21 sever symptoms of anxiety or depressin.

  2. Hospital Anxiety and Depression Scale (HADS)

    Time frame: 6 months

    questionnaries, range of 0-21 for either anxiety and depression subscores. Higher scores corresponding to worse outcomes. 0-7 normal; 8-10 borderline abnormal; 11-21 sever symptoms of anxiety or depressin.

  3. Hospital Anxiety and Depression Scale (HADS)

    Time frame: 12 months

    questionnaries, range of 0-21 for either anxiety and depression subscores. Higher scores corresponding to worse outcomes. 0-7 normal; 8-10 borderline abnormal; 11-21 sever symptoms of anxiety or depressin.

  4. SF-36 Health Survey

    Time frame: 2 months

    questionnaries to measure quality of life. 36 items. from 0 to 100, with 100 being the best health

  5. SF-36 Health Survey

    Time frame: 6 months

    questionnaries to measure quality of life. 36 items. from 0 to 100, with 100 being the best health

  6. SF-36 Health Survey

    Time frame: 12 months

    questionnaries to measure quality of life. 36 items. from 0 to 100, with 100 being the best health

  7. Revised Impact of Event Scales (IES-R)

    Time frame: 2 months

    questionnaries; measuring areas of hyperarousal, avoidance, and intrusion as subscales. Total score ranges from 0-88, higher score associated with worse PTSD symptoms. 1-22 mild PTSD,;22 signal clinically significant PTSD symptoms.

  8. Revised Impact of Event Scales (IES-R)

    Time frame: 6 months

    questionnaries; measuring areas of hyperarousal, avoidance, and intrusion as subscales. Total score ranges from 0-88, higher score associated with worse PTSD symptoms. 1-22 mild PTSD,;22 signal clinically significant PTSD symptoms.

  9. Revised Impact of Event Scales (IES-R)

    Time frame: 12 months

    questionnaries; measuring areas of hyperarousal, avoidance, and intrusion as subscales. Total score ranges from 0-88, higher score associated with worse PTSD symptoms. 1-22 mild PTSD,;22 signal clinically significant PTSD symptoms.

Study contacts

Contact information is provided by the study sponsor or research team.

Pilar Muñoz Rey

CONTACT

[email protected]

639534904

Sponsors and collaborators

Lead sponsor

University of Barcelona

Other

Registry information

Acronym: QUADERN

Important dates

Study start
2022
Primary completion
2025
Study completion
2026
First posted
Mar 21, 2022
Registry last updated
Mar 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.